Jpmorgan Chase & CO Thorne Healthtech, Inc. Transaction History

Jpmorgan Chase & CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$4.57 - $10.19 $9,542 - $21,276	-2,088 Reduced 18.66%	9,102 $92,000
Q2 2023 Aug 11, 2023	BUY	$4.35 - $4.91 $891 - $1,006	205 Added 1.87%	11,190 $52,000
Q1 2023 May 18, 2023	BUY	$3.54 - $5.02 $37,824 - $53,638	10,685 Added 3561.67%	10,985 $50,000
Q1 2023 May 11, 2023	SELL	$3.54 - $5.02 $26,489 - $37,564	-7,483 Reduced 96.15%	300 $1,000
Q4 2022 Feb 13, 2023	BUY	$3.5 - $5.12 $1,508 - $2,206	431 Added 5.86%	7,783 $28,000
Q2 2022 Aug 11, 2022	SELL	$4.75 - $7.34 $27,379 - $42,307	-5,764 Reduced 43.95%	7,352 $36,000
Q1 2022 May 11, 2022	BUY	$4.36 - $6.56 $41,367 - $62,241	9,488 Added 261.52%	13,116 $83,000
Q4 2021 Feb 10, 2022	BUY	$5.26 - $10.0 $19,083 - $36,280	3,628 New	3,628 $23,000

Ticker THRN
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 52,742,200
Description
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits fo...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.